About EndoVantage
EndoVantage is a company based in Scottsdale (United States) founded in 2013 was acquired by RapidAI in June 2020. EndoVantage has raised $450 thousand across 1 funding round from investors including RapidAI. EndoVantage operates in a competitive market with competitors including CathVision, YorLabs, Caption Care, DASI Simulations and Therenva, among others.
- Headquarter Scottsdale, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endovantage, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EndoVantage
EndoVantage has successfully raised a total of $450K through 1 strategic funding round. The most recent funding activity was a Seed round of $450 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EndoVantage
EndoVantage has secured backing from 1 investor. Prominent investors backing the company include RapidAI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of AI-based neuroimaging software for physicians
|
Locked | Locked | Locked |
Investor details for EndoVantage
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EndoVantage
Investment portfolio details for EndoVantage
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EndoVantage
Detailed financials for EndoVantage
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endovantage Comparisons
Peer comparison for EndoVantage
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EndoVantage
EndoVantage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CathVision, YorLabs, Caption Care, DASI Simulations and Therenva, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider and developer of an AI-based cardiac ablation therapy software and device
|
|
| Locked | Locked | Locked |
An AI-infused intracardiac echocardiography platform is developed for therapy guidance.
|
|
| Locked | Locked | Locked |
Early heart failure detection is facilitated by AI-guided ultrasound tools.
|
|
| Locked | Locked | Locked |
AI-based pre-procedural planning for structural heart surgery is offered.
|
|
| Locked | Locked | Locked |
AI-based imaging software for cardiovascular procedures is provided.
|
Detailed competitors of EndoVantage
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endovantage
Complete news archive for EndoVantage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoVantage
EndoVantage was founded in 2013 and raised its 1st funding round 2 years after it was founded.
EndoVantage is headquartered in Scottsdale, United States. It is registered at Scottsdale, Arizona, United States.
Robert Green is the current CEO of EndoVantage.
EndoVantage is a funded company, having raised a total of $450K across 1 funding round to date.
EndoVantage was founded in 2013 in Scottsdale, United States. Solutions for personalized planning of endovascular treatments are provided by the company. Treatment strategies are designed, and costs for different patient cases are compared through these tools. Operations center on the medical technology sector, with emphasis on endovascular procedures. Services support healthcare providers in strategy formulation and economic analysis for patient-specific interventions.
EndoVantage's top competitors include CathVision, Caption Care and YorLabs.
EndoVantage has 1 investor. Key investors include RapidAI.